BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• FDA

  Life Spine Announces FDA Approval of Neo(R)-SL

  June 25, 2007

   · 

  1 min read
• Deals

  MMI Investments Acquires 9.4% Stake in DJO Incorporated for $82.8 Million

  June 25, 2007

   · 

  1 min read
• Drug Development

  Roche Release: Earlier Initiation of Tamiflu(R) Treatment Improves Clinical Benefits for Children With Influenza

  June 25, 2007

   · 

  9 min read
• Drug Development

  DiObex, Inc. Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein

  June 25, 2007

   · 

  3 min read
• Biotech Bay

  DiObex, Inc. Announces Clinical Results of VLD(TM)-Glucagon for Nocturnal Hypoglycemia at the 67th Annual Scientific Sessions of the American Diabetes Association

  June 25, 2007

   · 

  3 min read
• BioMidwest

  Takeda’s Investigational DPP-4 Inhibitor Demonstrated Efficacy in Reducing Glucose Levels in Early Phase Study

  June 25, 2007

   · 

  5 min read
• Drug Development

  VeroScience Release: Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset(TM) in Patients with Type 2 Diabetes

  June 25, 2007

   · 

  7 min read
• BioMidwest

  The International Diabetes Federation Launches US$ 10 Million Grant Program to Improve Diabetes Care

  June 25, 2007

   · 

  4 min read
• Genetown

  IBC Life Sciences’S 2nd International Stem Cells: Building the Bridge From R&D to Commercialization Conference to Address the Latest Approaches to Capitalize on Stem Cell Scientific Advances for Successful Commercialization

  June 25, 2007

   · 

  1 min read
• Drug Development

  Sangamo BioSciences, Inc. Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting

  June 25, 2007

   · 

  13 min read